Effect of bacterial vaginosis, Lactobacillus and Premarin estrogen replacement therapy on vaginal gene expression changes
Authors:
- Sheri SaundersSSSheri Saunders
- Jo-Anne HammondJHJo-Anne Hammond
- David CarterDCDavid Carter
- Pirkka KirjavainenPKPirkka Kirjavainen
- Kingsley AnukamKAKingsley Anukam
- Gregor ReidGRGregor Reid
- 1 May 2008
- journal article
- Published by Elsevier in Microbes and Infection
- Vol. 10 (6) , 620-627
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Association between Lactobacillus species and bacterial vaginosis-related bacteria, and bacterial vaginosis scores in pregnant Japanese womenBMC Infectious Diseases, 2007
- Large‐scale mapping of human protein–protein interactions by mass spectrometryMolecular Systems Biology, 2007
- Breast response to menopausal hormone therapy—aspects on proliferation, apoptosis and mammographic densityAnnals of Medicine, 2007
- Management of Menopausal SymptomsNew England Journal of Medicine, 2006
- Vaginal microbial diversity among postmenopausal women with and without hormone replacement therapyCanadian Journal of Microbiology, 2005
- Potentiation of estrogen receptor transcriptional activity by breast cancer amplified sequence 2Biochemical and Biophysical Research Communications, 2005
- Detection of Atopobium vaginae in Postmenopausal Women by Cultivation-Independent Methods Warrants Further InvestigationJournal of Clinical Microbiology, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Expression, purification, and in vitro biological activities of recombinant bovine granulocyte-colony stimulating factorVeterinary Immunology and Immunopathology, 2001
- A Controlled Trial of Intravaginal Estriol in Postmenopausal Women with Recurrent Urinary Tract InfectionsNew England Journal of Medicine, 1993